The HSP90 inhibitor alvespimycin enhances the potency of telomerase inhibition by imetelstat in human osteosarcoma

A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer

(2014) A. A. Chiappori et al.   ANNALS OF ONCOLOGY

Effect of telomerase inhibition on preclinical models of malignant rhabdoid tumor

(2014) Yafang Hu et al.   Cancer Genetics

A Phase I Trial of Imetelstat in Children with Refractory or Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Study (ADVL1112)

(2013) P. A. Thompson et al.   CLINICAL CANCER RESEARCH

No end in sight for telomerase-targeted cancer drugs

(2013) Sarah C P Williams   NATURE MEDICINE

Targeting heat shock proteins in cancer

(2010) Gaëtan Jego et al.   CANCER LETTERS

The Telomerase Antagonist, Imetelstat, Efficiently Targets Glioblastoma Tumor-Initiating Cells Leading to Decreased Proliferation and Tumor Growth

(2010) C. O. Marian et al.   CLINICAL CANCER RESEARCH

Telomerase inhibitor GRN163L inhibits myeloma cell growth in vitro and in vivo

(2008) M A Shammas et al.   LEUKEMIA

Telomerase targeted oligonucleotidethio-phosphoramidates in T24-luc bladder cancer cells

(2007) Z. Gunnur Dikmen et al.   JOURNAL OF CELLULAR BIOCHEMISTRY